Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients

Background and Purpose: Tacrolimus (TAC) has been proven to be a rapid-acting, steroid-sparing agent for myasthenia gravis (MG) therapy. However, evidence related to the effectiveness of TAC alone is rare. Therefore, this study was performed to investigate the effect of TAC monotherapy in MG patient...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Neurol
Hlavní autoři: Fan, Zhirong, Li, Zunbo, Shen, Faxiu, Zhang, Xueping, Lei, Lin, Su, Shengyao, Lu, Yan, Di, Li, Wang, Min, Xu, Min, Da, Yuwei
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Neurology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652845/
https://ncbi.nlm.nih.gov/pubmed/33193063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.594152
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky